These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12654087)

  • 1. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis.
    Trujillo CM; Robledo SM; Franco JL; Velez ID; Erb KJ; Patiño PJ
    Parasite Immunol; 2002; 24(9-10):455-62. PubMed ID: 12654087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection.
    Bosque F; Saravia NG; Valderrama L; Milon G
    Scand J Immunol; 2000 May; 51(5):533-41. PubMed ID: 10792848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical and histopathologic characterization of lesions from patients with localized cutaneous leishmaniasis caused by Leishmania panamensis.
    Isaza DM; Restrepo M; Restrepo R; Caceres-Dittmar G; Tapia FJ
    Am J Trop Med Hyg; 1996 Oct; 55(4):365-9. PubMed ID: 8916790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.
    Sassi A; Louzir H; Ben Salah A; Mokni M; Ben Osman A; Dellagi K
    Clin Exp Immunol; 1999 Apr; 116(1):127-32. PubMed ID: 10209516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
    Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
    Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by
    Gonzalez K; Calzada JE; Corbett CEP; Saldaña A; Laurenti MD
    Mediators Inflamm; 2020; 2020():9278931. PubMed ID: 33192178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.
    Ehrlich AK; Fernández OL; Rodriguez-Pinto D; Castilho TM; Corral Caridad MJ; Goldsmith-Pestana K; Saravia NG; McMahon-Pratt D
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.
    Gonzalez K; Calzada JE; Tomokane TY; Pacheco CMS; Flores GVA; Castro Gomes CM; Pereira Corbett CE; Saldaña A; Laurenti MD
    Parasite Immunol; 2021 Mar; 43(3):e12801. PubMed ID: 33068443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis.
    Pascalis H; Lavergne A; Bourreau E; Prévot-Linguet G; Kariminia A; Pradinaud R; Rafati S; Launois P
    Infect Immun; 2003 May; 71(5):2924-6. PubMed ID: 12704171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
    Cabrera M; Blackwell JM; Castes M; Trujillo D; Convit J; Shaw MA
    Parasite Immunol; 2000 Feb; 22(2):73-9. PubMed ID: 10652119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses.
    Bourreau E; Gardon J; Pradinaud R; Pascalis H; Prévot-Linguet G; Kariminia A; Pascal L
    Infect Immun; 2003 Apr; 71(4):2244-6. PubMed ID: 12654849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
    Carvalho AM; Guimarães LH; Costa R; Saldanha MG; Prates I; Carvalho LP; Arruda S; Carvalho EM
    J Infect Dis; 2021 Feb; 223(3):527-535. PubMed ID: 32620011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru.
    Best I; Privat-Maldonado A; Cruz M; Zimic M; Bras-Gonçalves R; Lemesre JL; Arévalo J
    Front Cell Infect Microbiol; 2018; 8():289. PubMed ID: 30186774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.